Abstract:Background: Rectal cancer is a major mortality cause in the United States (US), and its treatment is based on individual risk factors for recurrence in each patient. In patients with rectal cancer, accurate assessment of response to chemoradiotherapy has increased in importance as the variety of treatment options has grown. In this scenario, a controversial non-operative approach may be considered in some patients for whom complete tumor regression is believed to have occurred. The recommended treatment for locally advanced rectal cancer (LARC, T3-4 ± N+) is total mesorectal excision (TME) after neoadjuvant chemoradiotherapy (nCRT). Magnetic resonance imaging (MRI) has become a standard technique for local staging of rectal cancer (tumor, lymph node, and circumferential resection margin [CRM] staging), in both the US and Europe, and it is getting widely used for restaging purposes. Aim: In our study, we aimed to use an MRI radiomic model to identify features linked to the different responses of chemoradiotherapy of rectal cancer before surgery, and whether these features are helpful to understand the effectiveness of the treatments. Methods: We retrospectively evaluated adult patients diagnosed with LARC who were subjected to at least 2 MRI examinations in 10–12 weeks at our hospital, before and after nCRT. The MRI acquisition protocol for the 2 exams included T2 sequence and apparent diffusion coefficient (ADC) map. The patients were divided into 2 groups according to the treatment response: complete or good responders (Group 1) and incomplete or poor responders (Group 2). MRI images were segmented, and quantitative features were extracted and compared between the two groups. Features that showed significant differences (SF) were then included in a LASSO regression method to build a radiomic-based predictive model. Results: We included 38 patients (26 males and 12 females), who are classified from T2 and T4 stages in the rectal cancer TNM. After the nCRT, the patients were divided into Group 1 (13 patients), complete or good responders, and Group 2 (25 patients), incomplete or poor responders. Analysis at baseline generated the following significant features for the Mann–Whitney test (out of a total of 107) for each sequence. Also, the analysis at the end of the follow-up yielded a high number of significant features for the Mann–Whitney test (out of a total of 107) for each image. Features selected by the LASSO regression method for each image analyzed; ROC curves relative to each model are represented. Conclusion: We developed an MRI-based radiomic model that is able to differentiate and predict between responders and non-responders who went through nCRT for rectal cancer. This approach might identify early lesions with high surgical potential from lesions potentially resolving after medical treatment.

Radiomics and Magnetic Resonance Imaging of Rectal Cancer: From Engineering to Clinical Practice

Rectal Cancer: Assessment of Neoadjuvant Chemoradiation Outcome based on Radiomics of Multiparametric MRI.

Radiomics in colorectal cancer patients

Artificial intelligence and radiomics in magnetic resonance imaging of rectal cancer: a review

Radiomics in Oncology, Part 1: Technical Principles and Gastrointestinal Application in CT and MRI

Rectal cancer MRI: protocols, signs and future perspectives radiologists should consider in everyday clinical practice

Radiomic Features Are Predictive of Response in Rectal Cancer Undergoing Therapy

Colorectal liver metastases patients prognostic assessment: prospects and limits of radiomics and radiogenomics

Radiomics in Oncology, Part 2: Thoracic, Genito-Urinary, Breast, Neurological, Hematologic and Musculoskeletal Applications

Radiomics for clinical decision support in radiation oncology

The Main Findings, Challenges and Limitations of the Methodologies

Rectal Cancer Magnetic Resonance Imaging: Imaging Beyond Morphology

The importance of MRI for rectal cancer evaluation

Radiomics and machine learning analysis based on magnetic resonance imaging in the assessment of liver mucinous colorectal metastases

Advances in MRI-Based Assessment of Rectal Cancer Post-Neoadjuvant Therapy: A Comprehensive Review

Radiomics of MRI for pretreatment prediction of pathologic complete response, tumor regression grade, and neoadjuvant rectal score in patients with locally advanced rectal cancer undergoing neoadjuvant chemoradiation: an international multicenter study

Radiomics and artificial intelligence in prostate cancer: new tools for molecular hybrid imaging and theragnostics

A radiomic approach for adaptive radiotherapy in non-small cell lung cancer patients

Radiomics in Oesogastric Cancer: Staging and Prediction of Preoperative Treatment Response: A Narrative Review and the Results of Personal Experience

Advances in radiomics research on efficacy evaluation of neoadjuvant therapy for gastrointestinal cancer

Radiomics systematic review in cervical cancer: gynecological oncologists' perspective